Startup Company Profile
CODA Genomics, Inc.
|
26061 Merit Circle #101 |
Employees: 30 |
||||||
|
Faculty Inventors:
|
|||||||
CODA is a Protein Translation Engineering company focused on proprietary approaches to express soluble, active, proteins across a variety of eukaryotic and prokaryotic cell lines. CODA was founded on two core competencies: ability to control the speed and stability of protein product at the ribosomal or “protein factory” level, and the ability to produce large numbers of self-assembling, directed, ribosomal instructions to enable synthetic biology. CODA works with partners to rationally design high impact solutions for protein research and development programs.
CODA develops recombinant proteins for therapeutics and industrial applications using proprietary Protein Translation Engineering® technologies. Through internal research programs and collaborations with strategic partners, CODA will enable the production of novel, active high value proteins.
The groundbreaking work of CODA’s co-founders resulted in a discovery and an invention which are having a profound impact on recombinant protein markets. The original work of Professors G. Wesley Hatfield and Rick Lathrop resulted in unique technologies licensed exclusively to CODA from the University of California Irvine. These capabilities along with years of experience in E. coli and yeast protein production formed the core of the company’s expertise and developed into a commercial entity in 2005 with the goal of solving complex protein expression problems. Today, CODA applies Translational Engineering to help solve challenging protein production problems.
